Cancer therapy market
Cancer Therapy Market, By Therapy Type (Chemotherapy, Target Therapy, Immunotherapy, Radiotherapy, and Others), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Liver Cancer, Thyroid Cancer, Head and Neck Cancer, Skin Cancer, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
- Apr 2024
- CMI5335
- 174 Pages
- Excel & Pdf
- Pharmaceutical
Summary
N/A
Table of Content
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Therapy Type
- Market Snapshot, By Cancer Type
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Acquisitions and Partnerships Scenario
- Reimbursement Scenario
- Epidemiology
- Treatment Algorithm (Patient Journey)
- Cancer Diagnosis and Treatment Options
- Pipeline Analysis
- Patient Advocacy and Empowerment
- Regulatory Scenario
- Pricing Analysis
- PEST Analysis
- PORTER’s Analysis
- Market Dynamics
- Global Cancer Therapy Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 impact on the market
- Global Cancer Therapy Market, By Therapy Type, 2019 – 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 – 2031
- Segment Trends
- Chemotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Alkylating agents
- Antimetabolites
- Anti-tumor antibiotics
- Others
- Target Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Monoclonal antibodies
- Small molecule inhibitors
- Others
- Immunotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Immune Checkpoint Inhibitors
- Oncolytic virus therapy
- T-cell therapy
- Radiotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Overview
- Global Cancer Therapy Market, By Cancer Type, 2019 – 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 – 2031
- Segment Trends
- Breast Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Lung Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Colorectal Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Prostate Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Blood Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Liver Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Thyroid Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Head and Neck Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Skin Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Overview
- Global Cancer Therapy Market, By Region, 2019 – 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020–2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Bn)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GSK plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Gilead Sciences, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boehringer Ingelheim International GmbH.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ADC Therapeutics SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F. Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eureka Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Fate Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sorrento Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Carrick Therapeutics Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Atara Biotherapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Celluris
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- NeoTX
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Kazia Therapeutics Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bristol-Myers Squibb Company
- Company Profiles
- Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
- References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
*Browse 48 market data tables and 44 figures on “Cancer Therapy Market” - Global forecast to 2031
Segmentation
Detailed Segmentation-
- Therapy Type:
- Chemotherapy
- Alkylating agents
- Antimetabolites
- Anti-tumor antibiotics
- Others
- Target Therapy
- Monoclonal antibodies
- Small molecule inhibitors
- Others
- Immunotherapy
- Immune Checkpoint Inhibitors
- Oncolytic virus therapy
- T-cell therapy
- Radiotherapy
- Others
- Chemotherapy
- Cancer Type:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Blood Cancer
- Liver Cancer
- Thyroid Cancer
- Head and Neck Cancer
- Skin Cancer
- Others
- Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Frequently Asked Questions -
What will be the CAGR of the cancer therapy market?
The CAGR of the cancer therapy market is projected to be 12.4% from 2024 to 2031.
What are the major factors driving the cancer therapy market growth?
Increasing product launch/approval and increasing investments and funding for cancer research are the major factors driving the growth of the cancer therapy market.
What are the key factors hampering the growth of the cancer therapy market?
High cost of cancer therapy and strict regulations for drug approval are the major factors hampering the growth of the cancer therapy market.
Which is the leading therapy type in the cancer therapy market?
In terms of therapy type, target therapy is estimated to dominate the market revenue share in 2024.
Which are the major players operating in the cancer therapy market?
Bristol-Myers Squibb Company, AstraZeneca, Pfizer Inc., Novartis AG, GSK plc., Sanofi, Bayer AG, Amgen Inc., Gilead Sciences, Inc., Boehringer Ingelheim International GmbH., ADC Therapeutics SA, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Eureka Therapeutics, Inc., AbbVie Inc., Fate Therapeutics, Sorrento Therapeutics, Inc., Carrick Therapeutics Limited, Atara Biotherapeutics, Inc., Celluris, NeoTX, and Kazia Therapeutics Limited are the major players.
Which region will lead the cancer therapy market?
North America is expected to lead the cancer therapy market.